Interval- and cycle-dependent combined effect of STING agonist loaded lipid nanoparticles and a PD-1 antibody
Alaa M. Khalifa, Takashi Nakamura, Yusuke Sato, Takanori Sato, Mamoru Hyodo, Yoshihiro Hayakawa, Hideyoshi Harashima
Topics & Concepts
StingAdjuvantMelanomaAgonistInterferonPharmacologyImmune systemBlockadeMedicineAntibodyImmunotherapyMetastasisCombination therapyCancer researchImmunologyCancerReceptorInternal medicineEngineeringAerospace engineeringinterferon and immune responsesImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers